Molecular response in long-term monitoring of patients with chronic myelogenic leukemia (CML) on nilotinib therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular response in long-term monitoring of patients with chronic myelogenic leukemia (CML) on nilotinib therapy

Published:2021-01-01 Issue:1 Volume:35 Page:650-656
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Nikolova Dragomira¹²,Damyanova Vera¹²,Radinov Atanas³,Toncheva Draga¹

Affiliation:

1. Department of Medical Genetics, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria

2. Genetic Laboratory, University Hospital “St.Ivan Rilski”, Sofia, Bulgaria

3. Clinic of Hematology, University Hospital “St.Ivan Rilski”, Sofia, Bulgaria

Publisher

Informa UK Limited

Subject

Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13102818.2021.1912639

Reference23 articles.

1. Monitoring Response and Resistance to Treatment in Chronic Myeloid Leukemia

2. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

3. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

4. Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Certainty in uncertainty: Determining the rate and reasons for reclassification of variants of uncertain significance in haematological malignancies;eJHaem;2024-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP